NM_002397.5(MEF2C):c.638-1G>A AND Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations

Clinical significance:Likely pathogenic (Last evaluated: Aug 2, 2020)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV001377142.1

Allele description [Variation Report for NM_002397.5(MEF2C):c.638-1G>A]

NM_002397.5(MEF2C):c.638-1G>A

Gene:
MEF2C:myocyte enhancer factor 2C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q14.3
Genomic location:
Preferred name:
NM_002397.5(MEF2C):c.638-1G>A
HGVS:
  • NC_000005.10:g.88731902C>T
  • NG_023427.1:g.177204G>A
  • NM_001131005.2:c.632-1G>A
  • NM_001193347.1:c.692-1G>A
  • NM_001193348.1:c.494-1G>A
  • NM_001193349.3:c.494-1G>A
  • NM_001193350.2:c.638-1G>A
  • NM_001308002.3:c.638-1G>A
  • NM_001363581.2:c.638-1G>A
  • NM_001364329.2:c.638-1G>A
  • NM_001364330.2:c.638-1G>A
  • NM_001364331.2:c.638-1G>A
  • NM_001364332.2:c.494-1G>A
  • NM_001364333.2:c.638-1G>A
  • NM_001364334.2:c.638-1G>A
  • NM_001364335.2:c.638-1G>A
  • NM_001364336.2:c.638-1G>A
  • NM_001364337.2:c.638-1G>A
  • NM_001364338.2:c.692-1G>A
  • NM_001364339.2:c.638-1G>A
  • NM_001364340.2:c.638-1G>A
  • NM_001364341.2:c.638-1G>A
  • NM_001364342.2:c.638-1G>A
  • NM_001364343.2:c.632-1G>A
  • NM_001364344.2:c.494-1G>A
  • NM_001364345.2:c.638-1G>A
  • NM_001364346.2:c.638-1G>A
  • NM_001364347.2:c.638-1G>A
  • NM_001364348.2:c.638-1G>A
  • NM_001364349.2:c.638-1G>A
  • NM_001364350.2:c.638-1G>A
  • NM_001364352.2:c.632-1G>A
  • NM_001364353.2:c.260-1G>A
  • NM_001364354.2:c.494-1G>A
  • NM_001364355.2:c.494-1G>A
  • NM_001364356.2:c.260-1G>A
  • NM_001364357.2:c.212-1G>A
  • NM_002397.5:c.638-1G>AMANE SELECT
  • NC_000005.9:g.88027719C>T
Molecular consequence:
  • NM_001131005.2:c.632-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001193347.1:c.692-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001193348.1:c.494-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001193349.3:c.494-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001193350.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001308002.3:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001363581.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364329.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364330.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364331.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364332.2:c.494-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364333.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364334.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364335.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364336.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364337.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364338.2:c.692-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364339.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364340.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364341.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364342.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364343.2:c.632-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364344.2:c.494-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364345.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364346.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364347.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364348.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364349.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364350.2:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364352.2:c.632-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364353.2:c.260-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364354.2:c.494-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364355.2:c.494-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364356.2:c.260-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001364357.2:c.212-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_002397.5:c.638-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:
Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations (NEDHSIL)
Synonyms:
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20; NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, STEREOTYPIC HAND MOVEMENTS, AND IMPAIRED LANGUAGE
Identifiers:
MONDO: MONDO:0013266; MedGen: C3150700; Orphanet: 228384; OMIM: 613443

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001574383Invitaecriteria provided, single submitter
Likely pathogenic
(Aug 2, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933

Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.

Zweier M, Gregor A, Zweier C, Engels H, Sticht H, Wohlleber E, Bijlsma EK, Holder SE, Zenker M, Rossier E, Grasshoff U, Johnson DS, Robertson L, Firth HV; Cornelia Kraus., Ekici AB, Reis A, Rauch A.

Hum Mutat. 2010 Jun;31(6):722-33. doi: 10.1002/humu.21253.

PubMed [citation]
PMID:
20513142
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV001574383.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change affects an acceptor splice site in intron 6 of the MEF2C gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MEF2C-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MEF2C are known to be pathogenic (PMID: 20513142). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 23, 2021

Support Center